1-(Tert-Butyl) 2-Methyl (2S)-4-Ethynylpyrrolidine-1,2-Dicarboxylate

Addition of 0.8–1.2 molar equivalents relative to azide-functionalized payloads in a copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) manifold constitutes the primary deployment pathway for this chiral pyrrolidine building block. The reaction proceeds in tetrahydrofuran/water (3:1 v/v) at ambient temperature under argon sparging, with sodium ascorbate (5 mol%) and copper(II) sulfate pentahydrate (2 mol%) generating the active Cu(I) species in situ. The stereochemical integrity at the C2 position—retained as the methyl ester—remains uncompromised provided the internal temperature never exceeds 28°C, a threshold established through accelerated racemization studies monitored via chiral HPLC (Chiralpak IA-3 column, hexane/isopropanol 85:15, 1.0 mL/min). Compliance with ICH Q3A guidelines for residual copper in pharmaceutical intermediates necessitates a post-reaction workup sequence: extraction with aqueous EDTA (0.1 M, pH 7.4), passage through a metal-scavenging functionalized silica cartridge (Silicycle SiliaMetS Thiol, 40–63 µm particle size), and final purification by flash chromatography on unbonded silica (230–400 mesh) with gradient elution from hexane/ethyl acetate 90:10 to 60:40. This process reliably delivers the triazole-linked intermediate with copper content below 10 ppm as quantified by inductively coupled plasma mass spectrometry (ICP-MS) per USP 〈232〉/〈233〉, enabling direct progression into amide bond formation or Boc deprotection sequences without additional metal remediation. Production-scale batches (5–20 kg) routinely employ jacketed glass-lined reactors with anchor agitators operating at 80–120 rpm to maintain sufficient interfacial contact during the biphasic EDTA extraction, and the methyl ester hydrolysis side reaction—which would generate the undesired free acid and complicate downstream coupling—is suppressed by maintaining the aqueous phase below pH 8.0 throughout all washes.

When Alkynyl-Proline Mimetics Anchor PROTAC Linker Conjugation

Targeted protein degradation platforms exploit the alkyne handle at the pyrrolidine 4-position as a conjugation point for E3 ligase-recruiting motifs via heterobifunctional linker arms. In a representative workflow, the fully protected intermediate is first subjected to selective N-Boc deprotection using trifluoroacetic acid (20% v/v in dichloromethane, 0°C to ambient over 2 hours) in the presence of triisopropylsilane (2% v/v) as a carbocation scavenger, yielding the secondary amine hydrochloride salt after precipitation from methyl tert-butyl ether. This amine is immediately acylated with a PEG_n-dioic acid monomethyl ester (n = 2, 4, or 6) using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl, 1.05 eq.) and 1-hydroxybenzotriazole hydrate (HOBt·H₂O, 1.05 eq.) in anhydrous N,N-dimethylformamide at 0–5°C under nitrogen. The methyl ester terminus of the PEG linker is subsequently hydrolyzed with lithium hydroxide (1.2 eq.) in tetrahydrofuran/water (2:1) at 0°C for 45 minutes—overexposure beyond 60 minutes leads to detectable (>0.5 area% by HPLC-UV at 210 nm) racemization at the C2 stereocenter. The resulting free acid participates in amidation with a cereblon-binding ligand (e.g., pomalidomide-4'-amine) under standard peptide coupling conditions, and the alkyne remains latent until the final convergent step. Propargylic proton abstraction is rigorously avoided by excluding strong bases (sodium hydride, lithium diisopropylamide) from any processing step post-alkyne installation. Compliance with FDA 21 CFR 210/211 current good manufacturing practice for active pharmaceutical ingredients dictates that all intermediates destined for in vivo efficacy studies undergo residual solvent analysis per USP 〈467〉, with particular attention to DMF (Class 2, limit 880 ppm) and dichloromethane (Class 2, limit 600 ppm). The terminal triazole formed after CuAAC with a von Hippel-Lindau or cereblon ligand-bearing azide displays a characteristic bathochromic shift in UV absorbance to 254–265 nm, facilitating preparative HPLC monitoring (C18 column, 10 µm, 250 × 50 mm, acetonitrile/water + 0.1% TFA gradient).

Precursor to Fmoc-(S)-4-Ethynylproline and Solid-Phase Peptide Synthesis Compatibility

Sequential deprotection and reprotection transforms the title compound into Fmoc-protected (2S)-4-ethynylpyrrolidine-2-carboxylic acid, a conformationally constrained amino acid surrogate for solid-phase peptide synthesis (SPPS). The two-step protocol commences with simultaneous methyl ester saponification and N-Boc cleavage under acidic rather than basic conditions to preserve alkyne integrity: a solution of the starting material in 4 M hydrogen chloride in 1,4-dioxane is stirred at ambient temperature for 16 hours, effecting both protecting group removals while the methyl ester is converted to the free carboxylic acid via acid-catalyzed hydrolysis. The crude (2S)-4-ethynylproline hydrochloride is isolated by filtration, washed with cold diethyl ether, and dried under vacuum at 40°C for 24 hours. Subsequent Fmoc protection employs Fmoc-OSu (1.1 eq.) in 10% aqueous sodium carbonate/dioxane (1:1) at 0–5°C for 4 hours, affording Fmoc-(S)-4-ethynylproline after acidification to pH 2–3 with 6 M HCl and extraction into ethyl acetate. The product is recrystallized from ethyl acetate/hexane (1:3) to achieve >99.5% diastereomeric purity as confirmed by chiral HPLC. In SPPS applications on Rink amide or Wang resin (loading 0.3–0.8 mmol/g), this monomer is coupled using HBTU (4 eq. relative to resin loading) and N,N-diisopropylethylamine (8 eq.) in DMF for 45 minutes at ambient temperature. The sterically hindered pyrrolidine nitrogen—now embedded within a secondary amine carbamate—exhibits reduced acylation kinetics compared to primary amine residues; double-coupling protocols are therefore standard for sequences exceeding 15 residues. Post-chain-assembly CuAAC on-resin derivatization (azide-bearing biotin, fluorophores, or PEG chains) is performed with tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA, 0.1 eq.) and tetrakis(acetonitrile)copper(I) hexafluorophosphate (0.1 eq.) in degassed DMF under microwave irradiation at 60°C for 20 minutes (CEM Liberty Blue peptide synthesizer, 50 W). Resin cleavage with trifluoroacetic acid/triisopropylsilane/water (95:2.5:2.5) for 2.5 hours liberates the modified peptide, which is precipitated from cold diethyl ether and purified by reversed-phase HPLC. This workflow falls under ICH Q7 good manufacturing practice guidance for active pharmaceutical ingredients when the target peptide is intended for clinical evaluation, requiring full traceability of the Fmoc monomer lot through to the final drug substance batch record.

Manufacture of 1,2,3-triazole-linked dendritic scaffolds using the alkyne-decorated pyrrolidine as the focal point or branching unit proceeds via iterative divergent CuAAC and ester deprotection cycles. The dendrimer core—typically a tris(azidomethyl)benzene or pentaerythrityl tetraazide derivative—is dissolved in degassed dimethyl sulfoxide containing the pyrrolidine alkyne (1.5 molar equivalents per azide group), copper(I) iodide (0.05 eq. per azide), and N,N-diisopropylethylamine (0.2 eq. per azide). The mixture is stirred under argon at 45°C for 18 hours, during which conversion is monitored by the disappearance of the azide asymmetric stretching band at 2090–2110 cm⁻¹ via Fourier-transform infrared spectroscopy (FTIR-ATR, diamond crystal, 4 cm⁻¹ resolution, 32 scans). Upon complete consumption of azide functionality, the methyl ester termini of the first-generation dendrimer are hydrolyzed to carboxylic acids using lithium bromide (3 eq. per ester) and triethylamine (3 eq. per ester) in acetonitrile/water (20:1) at reflux (82°C) for 12 hours, a method selected over aqueous sodium hydroxide to minimize alkyne hydration side-product formation. The polyacid intermediate is precipitated by acidification, converted to the corresponding poly(acyl chloride) using oxalyl chloride (2 eq. per acid group) and catalytic DMF in anhydrous dichloromethane, and subsequently reacted with excess 3-azidopropan-1-amine in the presence of triethylamine to install azide functionality at the periphery. Repetition of the CuAAC/hydrolysis/activation/azidolysis sequence through three generations yields a dendrimer with 27 surface azide groups, each available for bioorthogonal cargo attachment. Gel permeation chromatography (THF, 1 mL/min, polystyrene standards, refractive index detection) confirms a narrow polydispersity index (PDI < 1.08), and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS, α-cyano-4-hydroxycinnamic acid matrix, reflector positive mode) verifies molecular ion integrity. For biomedical-grade dendrimers intended as drug delivery vehicles, endotoxin testing per USP 〈85〉 (limulus amebocyte lysate assay, threshold 0.25 EU/mg) and residual copper quantification by ICP-MS (acceptance criterion < 5 ppm for parenteral administration) are mandated.

Anchoring Chiral Stationary Phases onto Azide-Modified Silica Gel

Grafting the (2S)-4-ethynylpyrrolidine scaffold onto azide-functionalized spherical silica gel (5 µm, pore size 100 Å, surface area 300 m²/g) generates a brush-type chiral stationary phase for enantioselective high-performance liquid chromatography. The bonding chemistry begins with the preparation of azide-activated silica: aminopropylsilica (prepared by refluxing bare silica with 3-aminopropyltriethoxysilane, 10% w/w in anhydrous toluene, 110°C, 24 hours) is treated with 4-azidobutyric acid N-hydroxysuccinimide ester (3 eq. relative to amine loading) in acetonitrile containing 1% v/v triethylamine at ambient temperature for 12 hours in the dark. Unreacted azide groups are capped with propiolic acid (0.1 M in methanol) to prevent subsequent non-specific binding. The alkyne-functionalized chiral selector—liberated from its N-Boc protecting group as described in previous sections—is then covalently attached via CuAAC: the azide-silica slurry in degassed methanol/water (1:1) is combined with the alkyne-pyrrolidine (1.5 eq. relative to azide surface density), copper(II) sulfate pentahydrate (0.05 eq.), and sodium ascorbate (0.25 eq.), and the suspension is gently agitated on an orbital shaker (120 rpm, 48 hours, ambient temperature, exclusion of light). The copper-chelated triazole-silica is washed sequentially with 0.1 M aqueous EDTA (until the filtrate is colorless), deionized water, methanol, and hexane before drying at 60°C under reduced pressure for 6 hours. The resulting chiral stationary phase is slurry-packed into a stainless-steel HPLC column (250 × 4.6 mm i.d.) at 6000 psi using methanol as the slurry and packing solvent. Enantioselectivity is evaluated according to the protocol described in the General Chapter of the European Pharmacopoeia 2.2.46 (Chromatographic Separation Techniques): a test mixture of racemic N-benzoyl-DL-proline methyl ester (0.1 mg/mL in mobile phase) is injected under isocratic conditions (hexane/2-propanol 90:10, 1.0 mL/min, 25°C, UV detection at 254 nm). Baseline resolution (Rs > 2.5) with retention factors k'₁ = 2.8 and k'₂ = 5.4 is typically observed, corresponding to an α-value of 1.93. Column-to-column reproducibility falls within RSD < 3% (n = 6) for retention times, meeting ICH Q2(R1) system suitability criteria for validated analytical procedures.

In energetic material binder systems that rely on azide-terminated glycidyl azide polymer (GAP) or poly(3,3-bis(azidomethyl)oxetane) (poly-BAMO), the bifunctional pyrrolidine alkyne serves as a low-temperature curing agent and mechanical property modifier. The curing reaction exploits the Huisgen cycloaddition between the alkyne and the pendant azidomethyl groups of the prepolymer—a process that proceeds without the evolution of volatile by-products, a critical advantage over isocyanate-based urethane cure chemistries in solid propellant grain formulations. Stoichiometry is calculated based on the azide content of the prepolymer (determined by ¹H NMR end-group analysis and confirmed by elemental analysis for nitrogen content per ASTM D5291-16) and adjusted to achieve a molar alkyne:azide ratio of 0.85:1.00, deliberately maintaining a slight azide excess to ensure complete alkyne consumption and eliminate unreacted low-molecular-weight alkyne migration during propellant aging. The alkyne and prepolymer are degassed separately under vacuum (< 1 mbar, 30°C, 1 hour), blended in a vertical planetary mixer (Netzsch PMH 2, 1 L capacity, vacuum < 10 mbar, 50 rpm blade speed for 15 minutes), and combined with copper(I) chloride (0.1 wt% relative to total binder) predissolved in a minimal volume of anhydrous acetonitrile. The pot life of the catalyzed mixture at 40°C exceeds 8 hours (viscosity monitored via Brookfield DV3T cone-and-plate rheometer, 25 mm cone, 1° angle, shear rate 10 s⁻¹), permitting adequate casting time for large-diameter ( > 300 mm) solid motor grains. Cure completion is verified by the disappearance of the azide IR absorption at 2100 cm⁻¹ (FTIR-ATR on a sample withdrawn at intervals) and by differential scanning calorimetry (DSC, 10°C/min, nitrogen atmosphere) confirming the absence of a residual exotherm below 200°C. The crosslinked elastomer exhibits a glass transition temperature of −42°C (DSC midpoint, ASTM E1356-08), tensile strength of 1.8 MPa, and elongation at break of 340% (Instron 5966 universal testing system, 500 N load cell, crosshead speed 50 mm/min, ASTM D412-16 Die C specimens). Safety qualification under the UN Manual of Tests and Criteria, Section 11.5 (Koenen test) and Section 13.6.1 (Series 3 friction sensitivity) confirms that the triazole-cured binder does not contribute to increased mechanical sensitivity relative to the neat GAP prepolymer. Processing waste streams containing copper(I) chloride-acetonitrile solutions are quenched with aqueous sodium sulfide (1 M) to precipitate copper sulfide, enabling heavy metal discharge compliance under local environmental regulations aligned with EU Industrial Emissions Directive 2010/75/EU.

Derivatization of the ethynyl group with a Staudinger-phosphite capture probe—specifically, 2-azidoethyl 2-(diphenylphosphino)benzoate—converts the pyrrolidine scaffold into an activity-based protein profiling (ABPP) reagent for serine hydrolase active-site labeling in complex proteomes. The alkyne-labeled probe is synthesized by CuAAC coupling (0.9 eq. azide relative to alkyne to ensure complete azide consumption, CuSO₄·5H₂O 1 mol%, sodium ascorbate 5 mol%, THF/H₂O 2:1, 12 hours, ambient temperature) followed by N-Boc deprotection (TFA/CH₂Cl₂ 1:3, 0°C, 30 minutes) and acylation of the liberated pyrrolidine nitrogen with a small-molecule serine hydrolase recognition element—typically a fluorophosphonate or diphenyl phosphonate electrophile—using HATU (1.1 eq.) and DIPEA (3 eq.) in DMF. The final probe is purified by semipreparative HPLC to >95% purity and characterized by high-resolution mass spectrometry and ³¹P NMR (202 MHz, CDCl₃, δ −3.5 to −5.0 ppm relative to 85% H₃PO₄ external standard). In a typical ABPP experiment conducted under institutional biosafety committee protocols aligned with OECD Series on Testing and Assessment No. 89 (Guidance on the Validation of In Vitro Methods), the probe is incubated with a murine liver proteome extract (1 mg/mL total protein in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Triton X-100) at a probe concentration of 5 µM for 30 minutes at 37°C. The probe-labeled proteome is then reacted with a rhodamine-azide reporter tag via CuAAC under standard conditions (TCEP 1 mM, TBTA 100 µM, CuSO₄ 1 mM, 1 hour, ambient temperature), separated by SDS-PAGE (4–12% Bis-Tris gradient gel, MOPS running buffer, 200 V, 45 minutes), and visualized by in-gel fluorescence scanning (Cy3/TAMRA channel, excitation 532 nm, emission 580 nm BP filter). Competitive ABPP with a known serine hydrolase inhibitor (e.g., methyl arachidonyl fluorophosphonate, MAFP, 10 µM preincubation for 15 minutes) should abolish >90% of the labeling signal to confirm target engagement specificity. Residual copper carried through from the click chemistry step is a known artifact in ABPP workflows—membrane proteins with exposed histidine-rich domains are particularly susceptible to non-specific copper-mediated oxidation—and must be controlled by the inclusion of 1 mM EDTA in the SDS-PAGE loading buffer.